No generic rollout
Any future licence should follow a defined use case, boundary and evidence requirement rather than an unrestricted organisation-wide release.
Future licensing model
A future licensing model governed by evidence.
RILayer is designed for licensed organisational use, but broader licensing should follow — not precede — evidence from bounded validation. Current work is focused on proving and validating the core mechanism through Youth Transition before wider commercial deployment is justified.
Commercial position
Start bounded. Prove value. Scale deliberately.
Future licensing routes explain the intended commercial architecture. Their availability and scope will depend on validation evidence, governance requirements and implementation readiness.
Validation first
Defined scope
Human authority retained
No unsupported scale claim
Commercial pathway
One route is current. Later licensing remains visibly evidence-dependent.
The progression below describes the intended commercial architecture rather than three immediately purchasable products.
Validation Partnership
Best for: Organisations willing to examine one bounded decision environment and retain evidence before wider adoption is considered.
Scope
A defined testable claim, governance boundary, evidence plan and controlled review process.
Typically includes
- decision-environment definition
- bounded validation design
- evidence and deviation record
- proceed / adapt / pause / stop review
Organisational Licence
Best for: Teams or functions where prior validation evidence supports repeatable internal use.
Scope
Potential wider adoption across agreed workflows and authorised users, subject to implementation readiness and governance requirements.
Not currently offered as a validated production route
Typically includes
- implementation architecture
- role and access structure
- governance controls
- review and renewal cycle
Sector / Network Licence
Best for: Networks or sector bodies where both the mechanism and transferability have been sufficiently validated.
Scope
A potential governed cohort model across multiple organisations, subject to evidence, readiness and network governance design.
Not currently offered as a validated production route
Typically includes
- organisation-level outputs
- appropriate aggregated learning
- shared implementation priorities
- network governance model
Where RILayer is now
Commercial architecture is visible. Commercial maturity is not overstated.
The current flagship proof-of-concept is Youth Transition / YT-WM-001. PAVRA Youth Transition is the intended next pilot pathway, subject to appropriate governance and partner agreement. Wider organisational licences remain downstream of evidence from validation and transferability testing.
Current validation focus
Youth Transition first. Transferability second. Licensing later.
That sequence protects the long-term commercial ambition by making the evidence threshold for expansion explicit.
View the current demonstrator →Licensing safeguards
Future commercial deployment remains governed by scope, authority and evidence.
A licence should make RILayer usable without weakening the organisation's responsibility, professional boundaries or ability to explain and review what happened.
No transfer of authority
RILayer does not acquire the organisation's professional, statutory, clinical, financial, legal, HR or regulatory authority.
No hidden dependency
The organisation retains its own decision owners, records, escalation routes and ability to stop or modify use.
No unsupported scale claim
Wider licensing should follow evidence from bounded validation and an explicit implementation-readiness review.
Current conversation
Bring a validation question before a licensing assumption.
A useful conversation now should clarify the decision environment, evidence threshold, governance boundaries and what a bounded validation exercise would need to establish.